Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 3-year overall survival update from the phase III CASPIAN study

Paz-Ares L., Chen Y., Reinmuth N., Hotta K., Trukhin D., Statsenko G., ...More

ANNALS OF ONCOLOGY, vol.32, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 32
  • Publication Date: 2021
  • Doi Number: 10.1016/j.annonc.2021.08.2142
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Istanbul University Affiliated: No